F NMR (376.5 MHz) spectra were recorded with a Bruker Avance 400 spectrometer. Splitting patterns are designed as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), or bs (broad singlet). IR spectra were recorded with a Jasco FT/IR-430 spectrometer. HRMS spectra were recorded with Orbitrap Exactive Mass spectrometer with ESI source. The appropriate o-(o-aminophenylethynyl) trifluoroacetanilides 5 and o-(oaminophenylethynyl)anilines 15 were prepared, usually in high yields, via a Sonogashira cross-coupling of 2-iodotrifluoroacetanilides or 2-iodoaniline with 2-ethynylanilines. were prepared via palladium-catalyzed cyclization of the corresponding o-(oaminophenylethynyl)aniline 15a-c (Scheme 1). 2 Indoles 14d,e (R 1 ≠ R 3 ) were obtained by cyclization of the corresponding o-(o-aminophenylethynyl) trifluoroacetanilides 5 with PdCl 2 (MeCN) 2 2 followed by hydrolysis of -COCF 3 on the crude (Scheme 2).
Typical procedure for preparation of indolo[1,2-c]quinazolines 13a-d. Preparation of 13d.
To a solution of 2-(1H-indol-2-yl)-4-methylaniline (14d, 76.7 mg, 0.345 mmol) in 2 mL of DMF, DMFDMA (91 L, 0.690 mmol) was added; the mixture was stirred at 100 °C. After 25 h, the reaction mixture was cooled to room temperature, diluted with ether and washed with a saturated solution of NaHCO 3 . The organic layer was dried over Na 2 SO 4 and concentrated under reduced pressure. The residue was purified by flash chromatography (silica gel, n-hexane/EtOAc 85/15 v/v) to afford 2-methylindolo[1,2-c]quinazoline 13d (76.1 mg, 95%).
Sequential preparation of indolo[1,2-c]quinazoline 13a from 15a
To a stirred solution of PdCl 2 (MeCN) 2 
2-(3-(4-Methoxyphenyl)-1H-indol-2-yl)aniline (9a)

12-(4-
Fluoro
